Rising Star: Sullivan & Cromwell's RuiHui 'Rachel' Yu

Law360 (August 26, 2026, 4:03 PM EDT) -- RuiHui "Rachel" Yu of Sullivan & Cromwell LLP helped Chinese biotechnology company MediLink Therapeutics craft an agreement granting Roche exclusive rights to commercialize its lead antibody-drug conjugate outside China, earning her...
To view the full article, register now.